BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22932866)

  • 41. Biological activity of lipopeptides from Bacillus.
    Zhao H; Shao D; Jiang C; Shi J; Li Q; Huang Q; Rajoka MSR; Yang H; Jin M
    Appl Microbiol Biotechnol; 2017 Aug; 101(15):5951-5960. PubMed ID: 28685194
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of some mycotoxigenic fungi by iturin A, a peptidolipid produced by Bacillus subtilis.
    Klich MA; Lax AR; Bland JM
    Mycopathologia; 1991 Nov; 116(2):77-80. PubMed ID: 1780001
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structural and Functional Insights into Iturin W, a Novel Lipopeptide Produced by the Deep-Sea Bacterium
    Zhou S; Liu G; Zheng R; Sun C; Wu S
    Appl Environ Microbiol; 2020 Oct; 86(21):. PubMed ID: 32859591
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antagonistic mechanism of iturin A and plipastatin A from Bacillus amyloliquefaciens S76-3 from wheat spikes against Fusarium graminearum.
    Gong AD; Li HP; Yuan QS; Song XS; Yao W; He WJ; Zhang JB; Liao YC
    PLoS One; 2015; 10(2):e0116871. PubMed ID: 25689464
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Purification and identification of two antifungal cyclic dipeptides from Bacillus cereus subsp. thuringiensis associated with a rhabditid entomopathogenic nematode especially against Fusarium oxysporum.
    Kumar SN; Nambisan B; Mohandas C
    J Enzyme Inhib Med Chem; 2014 Apr; 29(2):190-7. PubMed ID: 23402421
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NMR spectroscopic and MS/MS spectrometric characterization of a new lipopeptide antibiotic bacillopeptin B1 produced by a marine sediment-derived Bacillus amyloliquefaciens SH-B74.
    Ma Z; Hu J; Wang X; Wang S
    J Antibiot (Tokyo); 2014 Feb; 67(2):175-8. PubMed ID: 24064466
    [No Abstract]   [Full Text] [Related]  

  • 47. [Purification and identification of iturin A from Bacillus subtilis JA by electrospray ionization mass spectrometry].
    Chen H; Yuan C; Cai K; Zheng Z; Yu Z
    Wei Sheng Wu Xue Bao; 2008 Jan; 48(1):116-20. PubMed ID: 18338587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lipopeptide biosurfactant from Bacillus thuringiensis pak2310: A potential antagonist against Fusarium oxysporum.
    Deepak R; Jayapradha R
    J Mycol Med; 2015 Mar; 25(1):e15-24. PubMed ID: 25456418
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of fengycin from Bacillus subtilis fmbJ on apoptosis and necrosis in Rhizopus stolonifer.
    Tang Q; Bie X; Lu Z; Lv F; Tao Y; Qu X
    J Microbiol; 2014 Aug; 52(8):675-80. PubMed ID: 25098563
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synergistic effect of surfactin from Bacillus subtilis C4 and Achyrocline satureioides extracts on the viability of Paenibacillus larvae.
    Sabaté DC; Gonzaléz MJ; Porrini MP; Eguaras MJ; Audisio MC; Marioli JM
    World J Microbiol Biotechnol; 2012 Apr; 28(4):1415-22. PubMed ID: 22805922
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ralstonia solanacearum lipopeptide induces chlamydospore development in fungi and facilitates bacterial entry into fungal tissues.
    Spraker JE; Sanchez LM; Lowe TM; Dorrestein PC; Keller NP
    ISME J; 2016 Sep; 10(9):2317-30. PubMed ID: 26943626
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Roles of low pH, carbon and inorganic nitrogen source use in chlamydospore formation by Fusarium solani.
    Griffin GJ
    Can J Microbiol; 1976 Sep; 22(9):1381-9. PubMed ID: 10071
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Isolation and identification of lipopeptides produced by Bacillus subtilis using high performance liquid chromatography and electrospray ionization mass spectrometry].
    Chen H; Wang L; Yuan C; Zheng Z; Yu Z
    Se Pu; 2008 May; 26(3):343-7. PubMed ID: 18724673
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antimicrobial activity and spectroscopic characterization of surfactin class of lipopeptides from Bacillus amyloliquefaciens SR1.
    Nanjundan J; Ramasamy R; Uthandi S; Ponnusamy M
    Microb Pathog; 2019 Mar; 128():374-380. PubMed ID: 30695712
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Purification and characterization of antifungal peptide LP-1].
    Liu Y; Xu Q; Chen Z
    Wei Sheng Wu Xue Bao; 1999 Oct; 39(5):441-7. PubMed ID: 12555526
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modeling production of antifungal compounds and their role in biocontrol product inhibitory activity.
    Pryor SW; Siebert KJ; Gibson DM; Gossett JM; Walker LP
    J Agric Food Chem; 2007 Nov; 55(23):9530-6. PubMed ID: 17949051
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of a highly concentrated lipopeptide extract of Bacillus subtilis on fungal and bacterial cells.
    Etchegaray A; de Castro Bueno C; de Melo IS; Tsai SM; Fiore MF; Silva-Stenico ME; de Moraes LA; Teschke O
    Arch Microbiol; 2008 Dec; 190(6):611-22. PubMed ID: 18654762
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclic lipopeptide profile of the plant-beneficial endophytic bacterium Bacillus subtilis HC8.
    Malfanova N; Franzil L; Lugtenberg B; Chebotar V; Ongena M
    Arch Microbiol; 2012 Nov; 194(11):893-9. PubMed ID: 22648052
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Iturin A is the principal inhibitor in the biocontrol activity of Bacillus amyloliquefaciens PPCB004 against postharvest fungal pathogens.
    Arrebola E; Jacobs R; Korsten L
    J Appl Microbiol; 2010 Feb; 108(2):386-95. PubMed ID: 19674188
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Isolation and characterization of a new iturinic lipopeptide, mojavensin A produced by a marine-derived bacterium Bacillus mojavensis B0621A.
    Ma Z; Wang N; Hu J; Wang S
    J Antibiot (Tokyo); 2012 Jun; 65(6):317-22. PubMed ID: 22491138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.